EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Cold to Hot: Nanozyme‐Based Strategies for Reprogramming the Tumour Immunoenvironment

Yue Wang iD, Miao Xu, Yongshun Wang, Xuan Lin, Qiang Zhang, Xiaoning Lin, Xin Wu, Cheng Zhang iD, Wenhua Huang, Jianlin Shen iD

Cell Proliferation · 2026-07 · 59 (7)

DOI: 10.1111/cpr.70235 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Proliferation, online erschienen am 24.05.2026. Verfasst von Yue Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Affiliated Hospital of Putian University, School of Basic Medicine, Putian University, Putian, Fujian, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Nanostructures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 266 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, the Young and Middle-aged Teachers Educational Scientific Research Program of Fujian Province, the Startup Fund for Advanced Talents of Putian University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immunosuppressive tumour immune microenvironment (TIME) is a fundamental barrier that renders “cold” tumours resistant to conventional cancer immunotherapies. Nanozymes, catalytic nanomaterials with enzyme‐mimicking activities, have emerged as powerful and versatile agents for reprogramming the TIME and igniting robust antitumour immunity. This review systematically elucidates how nanozymes, through their multi‐enzyme catalytic properties, orchestrate a multifaceted attack on the immunosuppressive TIME by regulating reactive oxygen species, alleviating hypoxia, depleting antioxidants, and inducing immunogenic cell death, ferroptosis, and cuproptosis. These catalytic actions collectively promote dendritic cell maturation, enhance cytotoxic T lymphocyte infiltration, and repolarise tumour‐associated macrophages toward an M1 phenotype, thereby effectively converting immunologically “cold” tumours into “hot” ones. Furthermore, we deeply analyse the synergistic potential of nanozymes when integrated with established therapies—including immune checkpoint blockade, phototherapy, sonodynamic therapy, chemotherapy, and radiotherapy. Finally, by discussing advanced bioengineered platforms and addressing the ongoing challenges related to biosafety and clinical translation, we envision that nanozyme‐based catalytic immunoengineering represents a paradigm‐shifting approach for next‐generation combinatorial cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsNanostructuresHumansAnimalsImmunotherapyCuproptosisReactive Oxygen SpeciesFerroptosisImmunogenic Cell DeathCatalysis

Stichwörter der Autor:innen

cold tumourscombination therapiesimmunogenic cell deathnanozymestumour immunoenvironments

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Central Laboratory, Affiliated Hospital of Putian University, School of Basic Medicine, Putian University, Putian, Fujian, China.
  • Key Laboratory of Translational Tumour Medicine in Fujian Province, Putian University, Putian, Fujian, China.
  • School of Basic Medicine, Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Orthopedics, Affiliated Hospital of Putian University, Putian, Fujian, China.
  • Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
  • Guangdong Engineering Research Center for Translation of Medical 3D Printing Application, National Key Discipline of Human Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, Ch…

ORCID-Profile: Yue Wang, Cheng Zhang, Jianlin Shen

Förderung

  • Natural Science Foundation of Fujian Province
  • the Young and Middle-aged Teachers Educational Scientific Research Program of Fujian Province
  • the Startup Fund for Advanced Talents of Putian University
  • the Key Healthcare Projects of Putian
  • the Medical Research Foundation of Putian University
  • Science and Technology Bureau of Putian City

Zitieren

APA

Wang, Y., Xu, M., Wang, Y., Lin, X., Zhang, Q., Lin, X., Wu, X., Zhang, C., Huang, W., & Shen, J. (2026). From Cold to Hot: Nanozyme‐Based Strategies for Reprogramming the Tumour Immunoenvironment. Cell Proliferation, 59(7). https://doi.org/10.1111/cpr.70235

Vancouver

Wang Y, Xu M, Wang Y, Lin X, Zhang Q, Lin X, et al. From Cold to Hot: Nanozyme‐Based Strategies for Reprogramming the Tumour Immunoenvironment. Cell Proliferation. 2026;59(7). doi:10.1111/cpr.70235

BibTeX
@article{Wang2026,
  author = {Wang, Yue and Xu, Miao and Wang, Yongshun and Lin, Xuan and Zhang, Qiang and Lin, Xiaoning and Wu, Xin and Zhang, Cheng and Huang, Wenhua and Shen, Jianlin},
  title = {From Cold to Hot: Nanozyme‐Based Strategies for Reprogramming the Tumour Immunoenvironment},
  journal = {Cell Proliferation},
  year = {2026},
  volume = {59},
  number = {7},
  doi = {10.1111/cpr.70235}
}
Kostenlos starten →